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For the past 8 years, I served as the 
legal counsel assigned to the Board of 
Licensure in Medicine.  In that ca-
pacity, I worked closely with the Board 
staff regarding myriad issues related to 
complaints and investigations, licens-
ing, rule-making, and legislation. 
I also represented the State during 
Board adjudicatory hearings involving 
discipline and licensure.  
The Board’s mission is to pro-
tect the public, which it does in a 
variety of ways: through its licensing 
process, which verifies the education, training, and 
competency of applicants for licensure; through the 
complaint investigative process, which reviews and acts 
on complaints against physicians and physician assis-
tants; through education such as this newsletter and the 
guidelines posted on the Board’s website; and through 
the support of other organizations like the Medical 
Professionals Health Program, which provides valuable 
assistance to physicians and physician 
assistants.  
In addition, the Board protects 
the public by being aware of emerging 
issues in medicine such as “telemedi-
cine” and “license portability” – both 
of which can have an impact on access 
to care in rural states like Maine. The 
Board is able to perform this mission 
due to its capable and dedicated staff 
with whom it will be my privilege to 
work.  At present, the Board staff is 
working on a number of initiatives, 
including the implementation of on-line physician  
assistant licensing and updating the Board’s website.  
As I grow in this role, I hope to be able to provide 
education outreach regarding the Board and its  
services. I welcome your comments and suggestions 
about this education outreach goal, and other  
matters of concern to you. My email address is:  
dennis.smith@maine.gov. n 
New Executive Director
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On March 1, 2015, I assumed the position of Executive Director for the Board of Licensure in  Medicine.  Prior to assuming this position, I was privileged to serve for 14 ½ years as an Assistant Attorney General in the State of Maine Office of Attorney General. During that time I worked within the Professional and Financial Regulation Division, and provided legal advice and support  
to a number of occupational and professional licensing boards.  
BOLIMMAINE BOARD OF L ICENSURE IN MEDICINE 
Dennis E. Smith, J.D., Executive Director
Notes of a Psychiatry Watcher (with apologies to Lewis Thomas) 
George McNeil, M.D.
The Editor has kindly invited me to comment, on the eve of my retirement, from a perspec-tive that might represent a professional apex of 
sorts—or a nadir if one shares 
William Osler’s opinion on 
“the uselessness of men above 
sixty years of age.”1 Perhaps 
the reader will decide.
My license from Maine’s 
Board of Registration hangs, 
yellowing, before me, dated November, 1973. At the 
time, I experienced the Board as a welcoming old boys’ 
club. As such, I suppose it reflected the broader culture 
of American medicine. (This may sound a bit cyni-
cal, but discussions with women who were physicians 
at the time reveal that the club was not very welcoming 
to them.) In what has to be one of the most sweeping 
demographic shifts in the history of medicine, women 
now represent 47% of US 
medical students, according to a 
2013-14 census of the American 
Association of Medical Colleges. 
With the leveling of the educa-
tional playing field has emerged 
the dirty secret that women 
seem generally to be academically superior to their male 
counterparts.2  They certainly are better endowed with 
social and communication skills3—important assets as 
medical paternalism gives way to a new culture of shared 
decision making.
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 Notes of a Psychiatry Watcher (with apologies to Lewis Thomas) 
Dr. McNeil will step down this summer after  
35 years as Director of Resident Education in 
Psychiatry at Maine Medical Center.
1.  Osler, W.  The Fixed Period, from Aequanimitas With Other Addresses, 2nd ed. Blakiston: Philadelphia, 1925. 
2. Buchmann, C., DiPretz, T.  American Sociological Review; August, 2006.
3.  I admit that this last observation is highly informed by my life as a husband, father, and teacher.  For a more nuanced  
discussion of male deficiencies, see Daniel Goleman, The Brain and Emotional Intelligence, Psychology Today,  
April 29, 2011.
4.  For example see Psychiatric Genomics Consortium: Identification of risk loci with shared effects on five major  
psychiatric disorders: a genome wide analysis, Lancet, Feb. 27, 2013.
5. Yehuda, et al., American J. Psychiatry, August, 2014.
6.  For those interested in exploring this controversy, it has been nicely illuminated by former New England Journal 
of Medicine editor Marcia Angell, The Truth About Drug Companies, NY: Random House, 2004; and by Stanford 
anthropologist Tanya Luhrmann, Of Two Minds, NY: Vintage, 2001.
Of course the admission of women into the 
club has been paralleled by purposeful recruit-
ment by our colleges and medical schools of  
talented minorities. The old boys’ culture, 
which certainly eased my way into college and 
medical school, is becoming historic artifact; 
and I think that medicine is far better for the 
change. As I write, we are mid-way in our resi-
dency recruitment season—wherein I get to know 
a cross section of psychiatry’s future.  They are 
from all manner of races, classes, and ethnicities 
(many the children of recent immigrants). 
Various sexual orientations are discussed  
matter-of-factly, remarkable in a medical  
specialty that counted homosexuality as patho-
logic when I was in training. As a group they 
seem committed to social justice and service. 
Having grown up, perhaps, in a more tolerant 
and inclusive culture, they are better people 
than I—giving me hope 
for medicine’s future.
And they are  
entering a world of 
neuroscience and 
molecular medicine 
that is staggeringly 
exciting. The genomic 
revolution is beginning to shed light on the 
remarkable complexity of serious mental illness, 
casting doubt on our crude diagnostic catego-
rization, even on the newly minted Diagnostic 
and Statistical Manual (DSM-5). Big Science, 
practiced by large research consortia troll-
ing the genomes of thousands of patients and 
controls in genome wide association studies, has 
demonstrated multiple genes of interest which 
cut across traditional psychiatric diagnosis.4 
Similarly, modern functional neuroimaging 
belies our widely accepted categorical nosology. 
As a result, the National Institute of Mental 
Health has proposed a new schema, focusing on 
functional dimensions of behavior (like arousal, 
cognition, or negative affect). These so-called 
Research Domain Criteria (RDoC) indeed 
transcend DSM diagnoses and will drive the next 
generation of psychiatric research.
 At the same time, emerging findings in 
epigenetics remind us of the vital interplay of 
genes and life experience. By way of fascinating 
example, it has been shown that DNA methyla-
tion signatures in a promotor region of the 
glucocorticoid receptor gene are altered in 
children of male holocaust survivors—an example 
of trans-generational interaction of gene and 
environment that would warm the heart of any 
Lamarckian.5  
The point of this is that we can ill afford to 
ignore the patient’s life story. Yet the past few 
decades have seen an insidious retreat in psychi-
atry from psychotherapy and from a focus on the 
patient’s life narrative. No doubt this is driven 
in part by the “wow factor” of neuroscience. 
This, in turn, resonates with aggressive market-
ing by the pharmaceutical industry (whose latest 
unsavory practice involves direct-to-consumer 
appeals to “ask your doctor” for Abilify or some 
other agent you almost certainly don’t need) and 
by an insurance industry averse to the labor-
intensive process of spending time with patients. 
The resulting pharmacologic reductionism is 
seductive—simply match 
a DSM diagnosis, or even 
a symptom, to a drug…. 
Amazingly, this seems  
to work sometimes,  
but frequently it fails,  
remanding us to the 
harder but more sub-
stantive work of psychotherapy. Or, to the extent 
that we and our patients stay stuck in the thrall 
of the drug model, we may embark on an odys-
sey of medication trials. Again, these sometimes 
bear fruit. But too often they seem marked by 
futility, resulting  in bizarre poly-pharmacy (for 
example, the increasingly common daily cocktail 
combining stimulants and benzodiazepines— 
Valley of the Dolls, redux).6
Today’s trainees seem up to the task of 
confronting these challenges—if they can be kept 
from drowning in debt (school loans north of 
$300,000 for many) or from being utterly  
demoralized by the deluge of required paper-
work, e-learns, and meetings that distract them 
from patient care. The bloated bureaucracy  
that supports these mandates needs somehow  
to be reformulated if we hope to preserve the 
idealism of tomorrow’s physicians and to  
support the sacred in their work—fodder,  
perhaps, for a future screed. n
DESAI, ROBERT K., M.D.; License# 15475; 
2/10/15. On June 11, 2013, the licensee 
entered into an Interim Consent Agreement 
to the continued suspension of his license to 
practice medicine in the state of Maine until 
such time as the Board takes final action –  
either by hearing and decision and order or 
by Consent Agreement – regarding Com-
plaint No. CR 13-86. On February 10, 2015, 
the licensee entered into a Consent Agree-
ment that finally resolved complaint No. CR 
13-86 by surrendering his Maine medical 
license based upon: 1) habitual substance 
abuse that has resulted or is foreseeably likely 
to result in the licensee performing services in 
a manner that endangers the health or safety 
of patients, and 2) unprofessional conduct.
DOANE, STEPHEN H., M.D.; License 
#MD11995; 3/10/15. At the conclusion of 
an Adjudicatory Hearing held on February 
10, 2015, the Board voted to: 1) censure the 
licensee, and 2) place the licensee on proba-
tion. Terms of probation are as follows: 1) 
the licensee may oversee only one mid-level 
practitioner at a time for the remainder of 
his licensure, 2) the licensee may oversee 
no more than 200 beds in a maximum of 2 
facilities for the remainder of his licensure, 
3) the licensee may provide no longer than 
a 7-day prescription for patients leaving a 
facility he is employed at for the remainder of 
his licensure, and 4) the licensee will engage 
a practice monitor, approved by the Board, 
who will review all cases in which the licensee 
writes prescriptions for more than one week 
of controlled substances and report to the 
Board every four months for a period of one 
year. The Board voted to assess the licensee 
$12,000 in actual costs that have already 
been incurred by the Board in the execution 
of its investigation and enforcement duties in 
the matter, payable within 12 months.  These 
disciplinary actions are based on the Board’s 
findings and conclusions that the licensee 
had: 1) demonstrated incompetence, 2) 
engaged in unprofessional conduct, and 3) 
violated a Board Rule. 
ORVALD, THOMAS O., M.D.; License# 
MD19730; 2/10/15. In lieu of further proceed-
ings regarding complaint CR 14-85 Dr. Orvald 
concedes that should the matter proceed to 
an Adjudicatory Hearing, the Board would 
have sufficient evidence to conclude that he 
engaged in unprofessional conduct based 
upon information received from the state of 
Washington, Department of Health, Medical 
Quality Assurance Commission, regarding an 
Adverse Actions
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 action taken against Dr. Orvald’s medi-
cal license in that state for his conduct 
in qualifying a patient for the medical 
use of cannabis because asthma caused 
bronchospasms that was in violation of 
RCW 18.130.180(4). As discipline for this 
conduct, Dr. Orvald agrees to accept, and 
the Board agrees to issue, the following 
discipline: 1) prohibition during which time 
licensee shall not issue medical cannabis 
authorizations or certifications to any 
patients for the treatment of asthma, 2)  
monitoring by the Board until the monitor-
ing requirement is modified or rescinded 
in writing by agreement of all of parties to 
this Consent Agreement, and 3) licensee 
shall be responsible for all costs associated 
with his compliance with the terms and 
conditions of this Consent Agreement. 
HANDANOS, NICHOLAS M.D.;  
License # MD 16169; 12/9/14. In  
lieu of proceeding to an Adjudicatory 
Hearing, the licensee admits that with 
regard to complaint CR 13-131 the Board 
has sufficient evidence from which it could 
conclude that he engaged in: 1) unprofes-
sional conduct, and 2) incompetence. As 
discipline pertaining to CR 13-131, the 
licensee agrees to accept, and the Board 
agrees to issue the following discipline  for 
the mammography issue: 1) a reprimand,  
and 2) a fine of Five Hundred Dollars and 
Zero Cents ($500.00); and for  the CHF  
diagnosis and testing issue a reprimand, 
and a fine of Five Hundred Dollars and 
Zero Cents ($500.00). In addition, the 
licensee agreed to reimburse the Board 
Two Hundred Dollars and Fourteen Cents 
($200.14) for the actual costs of the  
investigation in this matter.
LEONG, KENG CHEONG M.D.; License 
# MD 7235; 12/9/14.  In lieu of proceeding 
to an Adjudicatory Hearing, the licensee 
admits that with regard to complaint CR 
14-44 the Board has sufficient evidence 
from which it could conclude that he 
engaged in: 1) unprofessional conduct, 2) 
incompetent medical care, 3) activity that 
was beyond the scope of the restrictions 
on his Maine medical license, and 4) activ-
ity that violated his Consent Agreement 
with the Board.  The licensee agrees to: 1) 
immediate and permanent surrender of his 
Maine medical license, and 2) reimburse 
the Board Nine Hundred and Twenty-eight 
Dollars and Eighty Cents ($928.80) as 
actual costs of investigation in this matter.
If a physician or physician assistant submits a renewal application while 
they have a complaint before the Board, it is the policy of the Board to 
pend the license renewal application until final action is taken on the  
complaint. The original license does not expire and Board staff will furnish  
a letter stating that. Occasionally, a pended license renewal does create  
difficulties for the licensee with credentialing agencies, third-party  
payers or Board-certification organizations. The Board policy allows for  
licensees who experience difficulty due to the pended status of their  
license to request a waiver and renewal of their license. Physicians and  
physician assistants who find themselves in this circumstance may write  
the Board explaining their difficulties and requesting a renewal of their 
license while the complaint process is on-going. n 
Did You Know?
Recently amended Board Rule Chapter 4 went into effect on March 10, 2015.   
The amended rule allows the Board staff to issue citations – resulting in an  
administrative fine of $200.00 – for the following:
n  Failure to report the existence of an outstanding complaint before the Maine Board 
of Licensure in Medicine against the applicant on a license application, license  
renewal application, or other document provided to the Board.
n  Failure to provide a response to the notice of a complaint within the statutorily  
specified 30 days from notice or within the timeframe specified by issuance of an 
extension of response as granted by Board staff.
n  Failure to answer accurately any question on any Board of Licensure in Medicine  
application.
n  Failure to submit a complete application for licensure within 14 days from issuance  
of an emergency license, unless a waiver has been granted.
n  Failure to meet Continuing Medical Education (CME) requirements at license renewal 
as confirmed by random audit.
Citations will be mailed to individuals, who will have the option of paying the $200 
administrative fine within 30 days, or filing a written response to the citation and re-
questing a hearing within that same timeframe. An individual who fails to take either of 
these actions within the prescribed 30-day period risks disciplinary action.  In addition, 
applications for licensure and/or re-licensure will not be further processed until the final 
resolution of the citation. The $200 administrative fine does not constitute discipline 
and is not reportable to the National Practitioner Data Bank or other similar entities. 
Amended Rule Regarding Citations
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Official publication of the Maine Board of Licensure in Medicine  n  Questions? Contact the Board Office at: 207 287-3601 
Free Online CME from the Federation  
of State Medical Boards (FSMB)
Internet Drug Sellers: What Providers Need to Know.  
This activity has been designated for 1.0 AMA PRA Category 
1 Credit(s) or one contact hour of continuing pharmacy  
education.
Safe Prescribing of Extended Release/Long-acting  
Opioids. Participants who complete all six modules will  
earn 3.0 AMA PRA Category 1 Credit(s) or three AOA  
Category 2B Credit(s).
FSMB Policies on Responsible Opioid Prescribing and 
Office-based Opioid Treatment. Both CME activities have 
been designated for 1.0 AMA PRA Category 1 Credit(s) each.
Responsible Opioid Prescribing: A Clinician’s Guide.  
This updated book offers clinicians effective strategies for 
reducing the risk of addiction, abuse and diversion of opioids 
that they prescribe for their patients in pain. Participants  
receive up to 7.25 hours of AMA PRA Category 1 Credit(s) 
free, with purchase of the book at $16.95.
Get started today by going to:  
www.fsmb.org/policy/education-meetings/
BOLIM Guidelines for Telemedicine
Telemedicine is a rapidly developing area of medicine,  
especially with regard to technology.  Physicians who are  
licensed in Maine and practicing telemedicine should be  
aware of the Board’s telemedicine guidelines. In September 
2014, the Board adopted guidelines for the practice of  
telemedicine, which include:
n  Where the practice of medicine occurs (where the patient is 
located)
n  Acceptable technology, which must include both audio and 
video or store and forward technology (audio only, telephone 
conversation, e-mail/instant messaging or fax are not  
acceptable)
n  Medical record keeping, including maintenance, accessibility, 
and confidentiality
n  Informed consent to treatment 
n  Physician-patient interaction needed to establish a diagnosis 
and treatment 
n  Primary care v. episodic care 
n  Prescribing  
The full text of the Board’s guidelines for each of these elements 
can be found on its website:  
http://docfinder.docboard.org/me/administrative/dw_policy.htm
 
